Dr. Gardner is a compassionate clinician who offers comprehensive psychiatric care. As both an endocrinologist and a psychiatrist, Dr. Gardner has special insight into patients suffering with overlapping hormonal and mood imbalances.
Dr. Gardner was rigorously trained at NYU, Stanford and Washington University. He has over forty years of experience restoring wellness in patients who have coped with challenging psychiatric disorders and adverse life circumstances.
Dr. Gardner contributed to the discovery of the genetic code by identifying the specific DNA nucleotides that encode animo acids.
Dr. Gardner is also an expert pharmacologist, with experience using novel treatments such as Ketamine infusions for the treatment of major depressive disorder. He excels at balancing medications in a nuanced fashion using conservative doses that in many cases results in remission of symptoms in patients that have been deemed treatment resistant. Dr. Gardner was an early proponent of using low doses of medications from other classes (e.g., lamictal) to augment response to antidepressants before this practice was widely adopted.
Dr. Gardner’s psychiatric care is said to be “comprehensive” because he draws upon all the available information, e.g., lab results, nutritional deficiencies, endocrine abnormalities (e.g., thyroid, estrogen or testosterone imbalances), and medical diseases that may contribute to an underlying psychiatric illness.
If you are in California and would like a consultation or further information you may contact me. (Due to license laws, I can’t consult with out-of-state patients unless they come into California.) My practice is currently located in Northern California, Sonoma County, in Santa Rosa.
Comprehensive Patient-Centered Care
The initial hour of a patient’s first session is designated for a complete evaluation of current and past issues as well as reviewing recent laboratory tests and radiological studies. The focus will be on signs and symptoms that relate to the neuroendocrine system. The first session often leads to recommendations for additional neuroendocrine laboratory studies to further evaluate the patient’s symptomatology. This is often followed by a second session to initiate discussions and suggestions for treatment using all available modalities.